COVID-19 Vaccination Program for Children: An Electronic Assessment of Symptoms

Naman Kumar1, Arjun Khora1, Riya Loomba1

  • 1Department of Pharmaceutial Sciences, Guru Gobind Singh College of Pharmacy, Yamuna Nagar, Haryana, India.

Current Drug Safety
|March 31, 2023
PubMed

Insights

COVID-19 vaccinations are crucial for public health. This study found that most side effects from Corbevax vaccines in Indian youth are mild and manageable, with common reactions including injection site pain and fever.

Area of Science:

  • Immunology
  • Public Health
  • Vaccinology

Background:

  • COVID-19 vaccines represent a significant scientific achievement in combating the pandemic.
  • Global research efforts have been pivotal in the rapid development of these vaccines.

Purpose of the Study:

  • To identify significant adverse reactions associated with COVID-19 vaccines in humans.
  • Focus on adverse events following immunization in a specific demographic.

Main Methods:

  • An online survey was conducted in Northern India utilizing Qualtrics CoreXM software.
  • 18 prototyped questionnaires were administered to gather data from vaccinated individuals.

Main Results:

  • Data from 286 Corbevax vaccine recipients (aged 12-18) were analyzed.
  • 70.98% reported side effects after the first dose; 50.62% after the second.
  • Common side effects included injection site pain, fever, fatigue, body aches, and headaches.

Conclusions:

  • COVID-19 vaccination in adolescents (12-18 years) is associated with generally mild and manageable side effects.
  • The study suggests that adverse reactions are infrequent and transient.
Abstract